L&K Appointed Lead Counsel Representing Eiger Biopharmaceuticals Investors

On February 3, 2023, a Lead Plaintiff was appointed in the class action lawsuit captioned Schoen v. Eiger Biopharmaceuticals, Inc., et al., 13:22-cv-6985-RS. Chief United States District Judge in the Northern District of California, Richard Seeborg, signed the order that also approved Levi & Korsinsky, LLP as lead counsel in the action. A copy of the order can be viewed here.

The L&K Team looks forward to representing class members who lost money investing in Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR).